NCT06755866 DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer
| NCT ID | NCT06755866 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yunnan Cancer Hospital |
| Condition | Esophageal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 135 participants |
| Start Date | 2024-11-26 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 135 participants in total. It began in 2024-11-26 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To prospectively collect medical images and clinical data related to esophageal cancer using 4D Free Breathing DCE-MRI technology, to evaluate the image quality in the diagnosis of esophageal cancer, and to predict the efficacy of preoperative neoadjuvant chemoradiotherapy for esophageal cancer.
Eligibility Criteria
Inclusion Criteria: 1. Be 18 years of age and older; 2. First diagnosis of esophageal squamous cell carcinoma confirmed by histopathological biopsy; 3. The clinical stage is cT1b\~cT2N+; or the clinical stage is cT3\~cT4 any N, (thoracic esophageal cancer, esophagogastric junction cancer); 4. There are no contraindications to MRI examination Exclusion Criteria: 1. Have other primary tumors; 2. The image quality does not meet the diagnostic criteria; 3. Those who do not cooperate with the inspection; 4. Patients who have received prior chemoradiotherapy
Contact & Investigator
Lianhua Ye
STUDY DIRECTOR
Ethics Committee of Yunnan Provincial Cancer Hospital
Frequently Asked Questions
Who can join the NCT06755866 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Esophageal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06755866 currently recruiting?
Yes, NCT06755866 is actively recruiting participants. Contact the research team at 1516559633@qq.com for enrollment information.
Where is the NCT06755866 trial being conducted?
This trial is being conducted at Kunming, China.
Who is sponsoring the NCT06755866 clinical trial?
NCT06755866 is sponsored by Yunnan Cancer Hospital. The principal investigator is Lianhua Ye at Ethics Committee of Yunnan Provincial Cancer Hospital. The trial plans to enroll 135 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.